11/12/2024 10:46 AM | BlackRock, Inc. (Filed by) Phathom Pharmaceuticals (Subject)
| Form SC 13G | |
11/07/2024 7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/05/2024 3:12 PM | Phathom Pharmaceuticals (Subject) PRUDENTIAL FINANCIAL INC (Filed by) PRUDENTIAL FINANCIAL INC (Filed by)
| Form SCHEDULE 13G/A | |
11/05/2024 2:32 PM | Phathom Pharmaceuticals (Subject) PRUDENTIAL FINANCIAL INC (Filed by) PRUDENTIAL FINANCIAL INC (Filed by)
| Form SCHEDULE 13G | |
11/04/2024 10:20 AM | JENNISON ASSOCIATES LLC (Filed by) Phathom Pharmaceuticals (Subject)
| Form SC 13G | |
10/21/2024 3:11 PM | BlackRock, Inc. (Filed by) Phathom Pharmaceuticals (Subject)
| Form SC 13G | |
08/22/2024 3:05 PM | Frazier Life Sciences Public Fund, L.P. (Filed by) Phathom Pharmaceuticals (Subject)
| Form SC 13D/A | |
|
08/19/2024 4:12 PM | Phathom Pharmaceuticals (Filer)
| Form 424B5 | |
08/19/2024 4:13 PM | Phathom Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/19/2024 5:05 AM | Phathom Pharmaceuticals (Subject)
| Form FWP | |
08/08/2024 7:06 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/18/2024 7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/17/2024 1:52 PM | Nabulsi Azmi (Reporting) Phathom Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/17/2024 1:50 PM | Curran Terrie (Reporting) Phathom Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/17/2024 1:51 PM | Henderson Molly (Reporting) Phathom Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2024 12:59 PM | Frazier Life Sciences Public Fund, L.P. (Filed by) Phathom Pharmaceuticals (Subject)
| Form SC 13D/A | |
05/31/2024 5:37 PM | Henderson Molly (Reporting) Phathom Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2024 5:34 PM | Nabulsi Azmi (Reporting) Phathom Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2024 3:30 PM | KARBE FRANK (Reporting) Phathom Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2024 6:33 PM | KARBE FRANK (Reporting) Phathom Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2024 6:43 PM | FIELDS HEIDI (Reporting) Phathom Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2024 6:44 PM | COLA MICHAEL F (Reporting) Phathom Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2024 6:46 PM | Parikh Asit (Reporting) Phathom Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2024 6:47 PM | Phathom Pharmaceuticals (Issuer) Topper James N (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2024 6:14 PM | Phathom Pharmaceuticals (Issuer) Socks David A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2024 6:18 PM | Phathom Pharmaceuticals (Issuer) Stenhouse Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2024 3:03 PM | Phathom Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2024 7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/10/2024 3:30 PM | Henderson Molly (Reporting) Phathom Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/10/2024 5:10 AM | Phathom Pharmaceuticals (Subject) TAKEDA PHARMACEUTICAL CO LTD (Filed by)
| Form SC 13D/A | |
04/01/2024 5:15 AM | Phathom Pharmaceuticals (Subject) TAKEDA PHARMACEUTICAL CO LTD (Filed by)
| Form SC 13D/A | |
03/26/2024 3:05 PM | Curran Terrie (Reporting) Phathom Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 7:06 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/13/2024 7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/26/2024 3:00 PM | Phathom Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/26/2024 3:00 PM | Medicxi Growth I LP (Filed by) Phathom Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/25/2024 5:13 AM | Phathom Pharmaceuticals (Issuer) TAKEDA PHARMACEUTICAL CO LTD (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/25/2024 5:11 AM | Phathom Pharmaceuticals (Subject) TAKEDA PHARMACEUTICAL CO LTD (Filed by)
| Form SC 13D/A | |
01/22/2024 7:19 PM | Curran Terrie (Reporting) Phathom Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2024 7:21 PM | Nabulsi Azmi (Reporting) Phathom Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2024 7:22 PM | Henderson Molly (Reporting) Phathom Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Buffett’s Selling Out: Is Your 401(k) About to Get Wiped Out? (Ad) Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of bank stocks. He didn't do it on a whim—he knows something big is coming.
The question is: Why aren't you taking action, too? Click Here For Your Free Guide |
12/14/2023 7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/06/2023 7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/28/2023 7:06 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/21/2023 3:40 PM | Henderson Molly (Reporting) Phathom Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/19/2023 11:15 PM | Phathom Pharmaceuticals (Filer)
| Form EFFECT | |